How can economic models inform decision-making about screening programmes?

Dr Elisabeth Adams, Managing Director and Founder of Aquarius Population Health, spoke at a continuing medical education webinar for health professionals hosted on September 23,2020 by the Consortium for Infectious Disease Control (CIDC).  

With increasing demands on time and resources, decision-makers in healthcare need information about how to create a safe, effective and cost-effective screening programme. Elisabeth discussed how theoretical quantitative evidence from health economic evaluations and models can inform decision-making, and guide policy decisions at local, regional, national and international levels in the absence of empirical data.

Continue reading

Using an mRNA versus DNA test in the English cervical screening programme can save £15m annually and reduce unnecessary testing

The results of our economic evaluation comparing the use of mRNA and DNA assays in screening for cervical cancer in England were published in BMJ Open and are now available online. Results show large cost savings from avoiding unnecessary testing and follow-up, which can benefit women and healthcare services.

Continue reading